samedan logo
 
 
 
spacer
home > pmps > Summer 2008
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Summer 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing
X-Ray systems are becoming increasingly valued by the pharmaceutical industry as an indispensable means of non-destructive testing; Martin Allen of Shaw Inspection Systems takes a closer look  
view
download pdf
The automated CheckWeighing system for dry powder inhalers supports the quality assurance process, outlines James Aitken of Aitken Scientific  
view
download pdf
Elisabethann Wright of Hogan & Hartson Brussels consider the European Commision’s attempts to strengthen the legal framework for regulating medical devices in Europe  
view
download pdf
Tom Roche at FM Global assesses how a single incident in one country can have a disastrous impact on the entire global economy  
view
download pdf
bullet
Drug Delivery 
Frances L DeGrazio at West Pharmaceutical Services, Inc, outlines the procedures involved and the importance of thorough testing in the leachables and extractables field  
view
download pdf
Stephen Grant at ANSYS discusses how computational fluid dynamics (CFD) enable a fast and cost-effective evaluation of new drug delivery systems and formulations  
view
download pdf
Douglas Custato at Helvoet Pharma outlines the options pharma companies will be presented with when choosing the ideal elastomeric closure  
view
download pdf
Andy Wallace at Comark Ltd encourages investment in wireless monitoring systems – a key tool for those looking to expand into emerging markets  
view
download pdf
bullet
Formulations, Ingredients and Excipients
Many active pharmaceutical ingredients are unstable and subject to degradation. The role of excipients is therefore being viewed as progressively more important. Nigel A Langley and Karen H Chen at Croda Inc (USA) explain how.  
view
download pdf
Dr Robert Hardy of Aesica explains to PMPS that exceptional service and a well-balanced business model is key in providing contract services to the outsourcing industry  
view
download pdf
bullet
IT and Logistics
Guido Moosmann of Schreiner MediPharm explores the latest innovative technologies for clinical trial supply management  
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING
John Haworth at Ditone Labels looks at how the pharma packaging industry has responded to the needs of the blind community  
view
download pdf
Nicole Golomb at 3S Simons Security Systems GmbH takes us through the various options available to avoid the counterfeit risk  
view
download pdf
Low and microdose powder filling in the pharmaceutical industry has traditionally been a challenging process. However, new developments are on the way, as Robin Davies of Isopak Ltd explains  
view
download pdf
bullet
COOL CHAIN
Robert Kayum at Kuehne + Nagel explores today’s climate for temperature-sensitive logistics, and the developments in solutions that can transform the role they play in the pharma industry  
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

New assurance first for plastic pollution reduction

Businesses in the pharmaceutical sector can now take significant verifiable steps to manage plastic waste and its impact on the environment, thanks to the launch of the world’s first best-practice standard for Responsible Plastic Management (RPM).
More info >>

White Papers

Backward Thinking: The Reverse Engineering of A Pressurized Metered Dose Inhaler

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market. Significant information about the reference marketed product can be obtained from a thorough review of published literature, specifically the Summary of Product Characteristics (SPC) and Patient Information Leaflet (PIL). Additionally, baselining the reference marketed product for pharmaceutical performance offers a working target specification for in-vitro correlation. It will ensure the smoothest possible path to commercialization and maximize return on investment. In addition, baselining of the reference marketed product is done to understand batch-to-batch variability and product performance over the stated shelf life to establish targets for critical quality attributes (CQAs), which can be applied to the generic equivalent pMDI.
More info >>

Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement